Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure

Journal of Clinical Pharmacology

Volumn 36, Issue 3, 1996, Pages 265-270

  Kramer, William G ^a   Smith, William B ^b   Ferguson, Jeffrey ^c   Serpas, Tina ^b   Grant III, Arthur G ^b   Black, Paula K ^c   Brater, D Craig ^c  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b Louisiana Cardiovascular Research Center   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CREATININE; ELECTROLYTE; SODIUM; TORASEMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIURESIS; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG HALF LIFE; DRUG URINE LEVEL; ECHOCARDIOGRAPHY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NATRIURESIS; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL;

EID: 0029984505     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04197.x     Document Type: Article

References (18)

1. Kaojarern S, Day B, Brater DC: The time course of delivery of furosemide into urine is an independent determinant of overall response. Kidney Int 1982;22:69-72.
2. Rudy DW, Voelker JR, Greene PK, Esparza FA, Brater DC: Loop diuretics for chronic renal insufficiency a continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991;115: 360-366.
3. van Meyel JJM, Dormans T, Smits P, Gerlag PGG, Russel FGM, Gribnau FWJ: Diuretic efficacy of different modes of administration of furosemide in patients with compensated and decompensated heart failure. Clin Pharmacol Ther 1992;51:440-444.
4. Lawson DH, Gray JMB, Henry DA, Tilstone WJ: Continuous infusion of frusemide in refractory oedema (letter). Br Med J 1978;2: 476.
5. Krasna MJ, Scott GE, Scholz PM, Spotnitz AJ, Mackenzie JW, Penn F: Postopeative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy. Chest 1986;89:294-295.
6. Copeland JG, Campbell DW, Plachetka JR, Salomon NW, Larson DF: Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg 1983;146:796-799.
7. Alván G, Helleday L, Lindholm A, Sanz E, Villén T: Diuretic effect and diuretic efficiency after intravenous dosage of frusemide. Br J Clin Pharmacol 1990;29:215-219.
8. Patterson JG, Adams KF Jr, Applefeld MM, Corder CN, Masse BR: Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Pharmacotherapy 1994;14:514-521.
9. Hariman RJ, Bremner S, Louie EK, Rogers WJ, Kostis JB, Nocero MA, Jones JP: Dose-response study of intravenous torsemide in congestive heart failure. Am Heart J 1994;128:352-357.
10. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC: Pharmacodynamics of torsemide in congestive heart failure. Clin Pharmacol Ther 1994;56:48-54.
11. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC: Bioavailability, pharmacokinetics, and pharmacodynamics of toremide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 1995;57:601-609.
12. March C, Farthing D, Wells B, Besenfelder E, Karnes HT: Solid phase extraction and liquid chromatography of torsemide and metabolites from plasma and urine. J Pharm Sci 1990;79:453-457.
13. Wittner M, Di Stefano A, Wangemann P, Greger R: How do loop diuretics act? Drugs 1991;41(Suppl 3):1-13.
14. Smith D: Loop diuretics: effects in an eliminating organ. In, Smith RB, Kroboth PD, Juhl RP (eds.): Pharmacokinetics and Pharmacodynamics, Volume 2: Current Problems, Potential Solutions. Cincinnati, OH: H. Whitney Books, 1988;107-138.
15. Hammerlund MM, Paazlow LK, Odlind B: Pharmacokinetics of furosemide in man. Eur J Clin Pharmacol 1984;26:197-207.
16. Gehr TWB, Rudy DW, Matzke GR, Kramer WG, Sica DA, Brater DC: The pharmacokinetics of torsemide in patients with chronic renal insufficiency. Clin Pharmacol Ther 1994;56:31-38.
17. Schwartz S, Brater DC, Pound D, Green PK, Kramer WG, Rudy D: Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis. Clin Pharmacol Ther 1993;54: 90-97.
18. Rudy DW, Gehr TWB, Matzke GR, Kramer WG, Sica DA, Brater DC: The pharmacodynamics of torsemide in patients with chronic renal insufficiency. Clin Pharmacol Ther 1994;56:39-47.